KATHLEEN GLENN: Open Payments
NPI 1386177749 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 30 payments from 8 companies in 2025. Trend: 2023 $1,085 · 2024 $1,147 · 2025 $556
Food & beverage: $457Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $215 |
| Novartis Pharmaceuticals Corporation | 7 | $125 |
| GENZYME CORPORATION | 3 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
| ABBVIE INC. | 3 | $44 |
| LEO Pharma Inc. | 2 | $32 |
| Incyte Corporation | 1 | $25 |
| Galderma Laboratories, L.P. | 1 | $21 |
Products named: TREMFYA, COSENTYX, DUPIXENT, RINVOQ, OPZELURA, NEMLUVIO, SPEVIGO, ADBRY.
Industry payments across KY — which companies pay providers there.
